IL10 and melanoma: IHC/IF analyses of melanoma lesions identified substantial populations of TGF-β-expressing and TNF-α-expressing CD20+ TIL-B in melanoma lesions, while the presence of IL-10+ TIL-B was less frequent (Figure 3(h)).